http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103272248-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2013-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103272248-B |
| titleOfInvention | The application of miR-15b in preparation treatment of diabetes preparation |
| abstract | The present invention relates to the application of miR-15b in preparation treatment of diabetes preparation.Announcement miR-15b or the insulin secretion that can promote beta Cell of islet that it is adjusted first, and then prevent and treat type 2 diabetes mellitus; Further, miR-15b or the prognostic marker of type 2 diabetes mellitus. |
| priorityDate | 2013-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 244.